114 related articles for article (PubMed ID: 26603761)
21. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
22. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization.
Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC
Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification, and therapeutic implications of recombinant sFRP1.
Ghoshal A; Ghosh SS
Appl Biochem Biotechnol; 2015 Feb; 175(4):2087-103. PubMed ID: 25432334
[TBL] [Abstract][Full Text] [Related]
24. Production of bioactive recombinant human fibroblast growth factor 12 using a new transient expression vector in E. coli and its neuroprotective effects.
Zhou M; Chen J; Meng K; Zhang Y; Zhang M; Lu P; Feng Y; Huang M; Dong Q; Li X; Tian H
Appl Microbiol Biotechnol; 2021 Jul; 105(13):5419-5431. PubMed ID: 34244814
[TBL] [Abstract][Full Text] [Related]
25. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effect of water extract of Panax ginseng on corticosterone-induced apoptosis in PC12 cells and its underlying molecule mechanisms.
Jiang Y; Li Z; Liu Y; Liu X; Chang Q; Liao Y; Pan R
J Ethnopharmacol; 2015 Jan; 159():102-12. PubMed ID: 25446601
[TBL] [Abstract][Full Text] [Related]
27. Expression of a novel dual-functional protein--the antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli.
Shen J; Lu XM; Jin XB; Ding J; Li XB; Mei HF; Chu FJ; Zhu JY
Protein Expr Purif; 2012 Jan; 81(1):119-125. PubMed ID: 21963769
[TBL] [Abstract][Full Text] [Related]
28. An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies.
Ye X; Yu D; Wu Y; Han J; Li S; Wu Q; Li D; Qi J
Int J Biol Macromol; 2019 Aug; 135():362-372. PubMed ID: 31129207
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive activity of recombinant peptide IYPR expressed in Escherichia coli as inclusion bodies.
Huang L; Ma H; Li Y; Li S
Protein Expr Purif; 2012 May; 83(1):15-20. PubMed ID: 22381462
[TBL] [Abstract][Full Text] [Related]
30. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
31. SHuffle™ T7 strain is capable of producing high amount of recombinant human fibroblast growth factor-1 (rhFGF-1) with proper physicochemical and biological properties.
Nasiri M; Babaie J; Amiri S; Azimi E; Shamshiri S; Khalaj V; Golkar M; Fard-Esfahani P
J Biotechnol; 2017 Oct; 259():30-38. PubMed ID: 28827102
[TBL] [Abstract][Full Text] [Related]
32. High-level expression and purification of soluble bioactive recombinant human heparin-binding epidermal growth factor in Escherichia coli.
Khalili M; Soleyman MR; Baazm M; Beyer C
Cell Biol Int; 2015 Jul; 39(7):858-64. PubMed ID: 25712700
[TBL] [Abstract][Full Text] [Related]
33. Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli.
Dang S; Hong T; Bu D; Tang J; Fan J; Zhang W
Protein Expr Purif; 2012 Mar; 82(1):32-6. PubMed ID: 22119775
[TBL] [Abstract][Full Text] [Related]
34. Triptolide attenuated injury via inhibiting oxidative stress in Amyloid-Beta25-35-treated differentiated PC12 cells.
Xu P; Wang H; Li Z; Yang Z
Life Sci; 2016 Jan; 145():19-26. PubMed ID: 26679104
[TBL] [Abstract][Full Text] [Related]
35. [Cloning, expression, renaturation and purification of soluble hSCF].
Wang LL; Geng XD; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):402-5. PubMed ID: 15207080
[TBL] [Abstract][Full Text] [Related]
36. High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil.
Sun QM; Jiang HC; Xu WM; Liu X; Dai CB; Sun MS
Protein Expr Purif; 2005 Aug; 42(2):278-85. PubMed ID: 15935697
[TBL] [Abstract][Full Text] [Related]
37. [Efficient expression of soluble human FGF-21 and its glucose regulation activity].
Ren GP; Hou YT; Jiang YY; Li JN; Zhang W; Di L; Li DS
Yao Xue Xue Bao; 2009 May; 44(5):548-52. PubMed ID: 19618734
[TBL] [Abstract][Full Text] [Related]
38. High cell density cultivation of recombinant Escherichia coli for prodrug of recombinant human GLPs production.
Zhou Y; Ma X; Hou Z; Xue X; Meng J; Li M; Jia M; Luo X
Protein Expr Purif; 2012 Sep; 85(1):38-43. PubMed ID: 22771632
[TBL] [Abstract][Full Text] [Related]
39. Large-scale expression, purification, and glucose uptake activity of recombinant human FGF21 in Escherichia coli.
Zhang M; Jiang X; Su Z; Lin J; Xiang Q; Yang Z; Huang Y; Li X
Appl Microbiol Biotechnol; 2012 Jan; 93(2):613-21. PubMed ID: 21713513
[TBL] [Abstract][Full Text] [Related]
40. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
